191 related articles for article (PubMed ID: 19695401)
1. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W
Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
[TBL] [Abstract][Full Text] [Related]
2. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
3. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.
Xin HW; Xiong H; Wu XC; Li Q; Xiong L; Yu AR
Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245
[TBL] [Abstract][Full Text] [Related]
4. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
Kurzawski M; Dziewanowski K; Lener A; Drozdzik M
Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
[TBL] [Abstract][Full Text] [Related]
6. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
Song DK; Zhao J; Zhang LR
J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
[TBL] [Abstract][Full Text] [Related]
7. TPMT*26 (208F-->L), a novel mutation detected in a Chinese.
Kham SK; Soh CK; Aw DC; Yeoh AE
Br J Clin Pharmacol; 2009 Jul; 68(1):120-3. PubMed ID: 19660010
[TBL] [Abstract][Full Text] [Related]
8. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients.
Formea CM; Myers-Huentelman H; Wu R; Crabtree J; Fujita S; Hemming A; Reed A; Howard R; Karlix JL
Am J Transplant; 2004 Nov; 4(11):1810-7. PubMed ID: 15476481
[TBL] [Abstract][Full Text] [Related]
11. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine.
Jun JB; Cho DY; Kang C; Bae SC
Clin Exp Rheumatol; 2005; 23(6):873-6. PubMed ID: 16396707
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.
Carvalho AT; Esberard BC; Fróes RS; Rapozo DC; Grinman AB; Simão TA; Santos JC; Carneiro AJ; Ribeiro-Pinto LF; de Souza HS
World J Gastroenterol; 2014 Mar; 20(12):3327-34. PubMed ID: 24696613
[TBL] [Abstract][Full Text] [Related]
13. Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia.
Hongeng S; Sasanakul W; Chuansumrit A; Pakakasama S; Chattananon A; Hathirat P
Med Pediatr Oncol; 2000 Oct; 35(4):410-4. PubMed ID: 11025471
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C.
Tassaneeyakul W; Srimarthpirom S; Reungjui S; Chansung K; Romphruk A; Tassaneeyakul W
Transplantation; 2003 Jul; 76(1):265-6. PubMed ID: 12865824
[No Abstract] [Full Text] [Related]
15. Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.
Tamori A; Shinzaki M; Kosaka S; Hayashi T; Iwai S; Enomoto M; Habu D; Sakaguchi H; Kawada N; Hino M; Shiomi S; Nishiguchi S
Liver Int; 2007 Feb; 27(1):95-100. PubMed ID: 17241387
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathioprine-related adverse events.
Heckmann JM; Lambson EM; Little F; Owen EP
J Neurol Sci; 2005 Apr; 231(1-2):71-80. PubMed ID: 15792824
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine S-methyltransferase (TPMT) Mutation Prevalence and Myelosuppression Frequency in North Indian Patients with Autoimmune Disorders.
Ambar G; Vandana A; Lalit D; Jyoti K
J Assoc Physicians India; 2018 May; 66(5):39-44. PubMed ID: 30477053
[TBL] [Abstract][Full Text] [Related]
18. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients.
Chrzanowska M; Kurzawski M; Droździk M; Mazik M; Oko A; Czekalski S
Pharmacol Rep; 2006; 58(6):973-8. PubMed ID: 17220558
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.
Sebbag L; Boucher P; Davelu P; Boissonnat P; Champsaur G; Ninet J; Dureau G; Obadia JF; Vallon JJ; Delaye J
Transplantation; 2000 Apr; 69(7):1524-7. PubMed ID: 10798786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
